Manifestaciones acrales asociadas a infecciones

1. McMahon DE, Gallman AE, Hruza GJ, et al. Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. Lancet Infect Dis. 2021; 21(3):313-314.10.1016/S1473 -3099 (20)30986 -5

2. Neri I, Patrizi A, Gabrielli L, et al. Acral skin eruption observed during SARS-CoV-2 pandemic: possible keratolysis exfoliativa with red palms and soles. J Eur Acad Dermatol Venereol. 2020; 34(12):e78 3-e785. 10.1111/jdv.16881

3. Andina D, Belloni-Fortina A, Bodemer C, et al. Skin manifestations of COVID-19 in children: part 1. Clin Exp Dermatol. 2021; 46(3):444-450. 10.1111/ced.14481

4. Andina-Martinez D, Villaizan-Perez C, Pavo-Garcia MR, et al. Acral peeling as the sole skin manifestation of COVID-19 in children. Pediatr Dermatol. 2021; 38(3):664-666. 10.1111/pde.14599

5. Mehta P, Bunker CB, Ciurtin C, et al. Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy. Lancet Infect Dis. 2021;21(7):912. 10.1016/S1473-3099(21)00133 -X

6. Freeman EE, McMahon DE, Lipoff JB, et al. The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020;83(4):1118-1129. 10.1016/j.jaad.2020.06.1016

7. Andina D, Belloni-Fortina A, Bodemer C, et al. Skin manifestations of COVID-19 in children: part 2. Clin Exp Dermatol. 2021; 46(3):451-461. 10.1111/ced.14482

8. Andina D, Belloni-Fortina A, Bodemer C, et al. Skin manifestations of COVID-19 in children: part 3. Clin Exp Dermatol. 2021; 46(3):462-472. 10.1111/ced.14483

9. Jimenez-Cauhe J, Ortega-Quijano D, Carretero-Barrio I, et al. Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings. Clin Exp Dermatol.

2020; 45(7):892-895. 10.1111/ced.14281

10. McMahon DE, Amerson E, Rosenbach M, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021; 85(1):46-55. 10.1016/j.jaad.2021.03.092

11. Hoste L, Van Paemel R, Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr. 2021; 180(7):2019-2034. 10.1007/s0043 1-021-03993-5

12. Radia T, Williams N, Agrawal P, et al. Multi-system inflammatory syndrome in children & adolescents (MIS-C): a systematic review of clinical features and presentation. Paediatr Respir Rev. 2021; 38:51-57.10.1016/j.prrv.2020.08.001

13. Galeotti C, Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol. 2020; 16(8):413-414. 10.1038/s4158 4-020-0448-7

14. Pouletty M, Borocco C, Ouldali N, et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis. 2020; 79(8):999-1006. 10.1136/annrh eumdis-2020-217960

15. Folster-Holst R, Kreth HW. Viral exanthems in childhood–infectious (direct) exanthems. part 2: other viral exanthems. J Dtsch Dermatol Ges. 2009; 7(5):414-419. 10.1111/j.1610-0387.2008.06869.x

16. Knopfel N, Noguera-Morel L, Latour I, Torrelo A. Viral exanthems in children: a great imitator. Clin Dermatol. 2019; 37(3):213-226. 10.1016/j.clind ermat ol.2019.01.009

17. Folster-Holst R. Vesicles, pustules and vesiculopustules in early childhood. Hautarzt. 2020;71(10):809-826. Vesikeln, Pusteln und Vesikulopusteln im fruhen Kindesalter. 10.1007/s0010 5-020-04678-0

18. Chen WW, Yang ZB, Lian LS, Xu LP. Case report: features of hand, foot and mouth disease in neonates. Medicine (Baltimore). 2017; 96(42):e8307. 10.1097/MD.00000 00000 008307

19. American Academy of Pediatrics. Enterovirus (Non poliovirus). In Kimberlin DW, Brady MT, Jackson MA, Long S (Eds.). Red Book: 2018-2021 Report of the Committee on Infectious Diseases. 31th edition. AAP Committee on Infectious Diseases; 2021:331-334.

20. Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J Am Acad Dermatol. 2007; 57(5):737-763.10.1016/j.jaad.2007.06.027

21. Looker KJ, Magaret AS, May MT, et al. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One. 2015; 10(10):e0140765. 10.1371/journal.pone.0140765

22. Cunningham AL, Diefenbach RJ, Miranda-Saksena M, et al. The cycle of human herpes simplex virus infection: virus transport and immune control. J Infect Dis. 2006; 194(Suppl. 1):S11-S18. 10.1086/505359

23. Kimberlin DW, Rouse DJ. Clinical practice genital herpes. N Engl J Med. 2004; 350(19):1970-1977. 10.1056/NEJMc p023065

24. Szinnai G, Schaad UB, Heininger U. Multiple herpetic whitlow lesions in a 4-year-old girl: case report and review of the literature. Eur J Pediatr. 2001; 160 (9):528-533. 10.1007/s0043 10100800

25. Osio A, Fremont G, Petit A, et al. An unusual bipolar primary herpes simplex virus 1 infection. J Clin Virol. 2008; 43(2):230-232. 10.1016/j.jcv.2008.06.017

26. Jimenez Gomez N, Martinez MA, Grillo E, Jaen OP. Recurrent palmar blister. Aust Fam Physician. 2014; 43(5):307-308.

27. Walker LG, Simmons BP, Lovallo JL. Pediatric herpetic hand infections. J Hand Surg Am. 1990; 15(1):176-180. 10.1016/s0363-5023(09)91128 -5

28. Amir J. Clinical aspects and antiviral therapy in primary herpetic gingivostomatitis. Paediatr Drugs. 2001; 3(8):593-597. 10.2165/00128072-200103080-00004

29. Shoji K, Komuro H, Miyata I, Miyairi I, Saitoh A. Dermatologic manifestations of human parechovirus type 3 infection in neonates and infants. Pediatr Infect Dis J. 2013; 32(3):233-236. 10.1097/INF.0b013 e3182 7b1fd0

30. Yeom JS, Park JS, Seo JH, et al. Distinctive clinical features of HPeV-3 infection in 2 neonates with a sepsis-like illness. Korean J Pediatr. 2016; 59(7):308-311. 10.3345/kjp.2016.59.7.308

31. Bergqvist C, Kurban M, Abbas O. Orf virus infection. Rev Med Virol. 2017;27:4. 10.1002/rmv.1932

32. Georgiades G, Katsarou A, Dimitroglou K. Human ORF (ecthyma contagiosum). J Hand Surg Br. 2005; 30(4):409-411.10.1016/j.jhsb.2005.03.010

33. Hosamani M, Scagliarini A, Bhanuprakash V, McInnes CJ, Singh RK. Orf: an update on current research and future perspectives. Expert Rev Anti Infect Ther. 2009; 7(7):879-893. 10.1586/eri.09.64

34. Fretzayas A, Douros K, Moustaki M, Nicolaidou P. Papular-purpuric gloves and socks syndrome in children and adolescents. Pediatr Infect Dis J. 2009; 28(3):250-252. 10.1097/INF.0b013 e3181 8cb289

35. Kappers W, Stevens G, Bruynseels P, van den Akker M. Papular purpuric gloves and socks syndrome because of a mycoplasma infection. J Pediatr. 2018; 194:258. 10.1016/j.jpeds.2017.10.050

36. Hsieh MY, Huang PH. The juvenile variant of papular-purpuric gloves and socks syndrome and its association with viral infections. Br J Dermatol. 2004; 151(1):201-206.10.1111/j.1365-2133.2004.05946.x

37. Ferrieri P, Gewitz MH, Gerber MA, et al. Unique features of infective endocarditis in childhood. Circulation. 2002;105(17):2115-2126. 10.1161/01.cir.00000 13073.22415.90

38. Usui S, Dainichi T, Kitoh A, Miyachi Y, Kabashima K. Janeway lesions and splinter hemorrhages in a patient with eosinophilic endomyocarditis. JAMA Dermatol. 2015; 151(8):907-908. 10.1001/jamadermat ol.2015.0388

39. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European society of cardiology (ESC). Eur Heart J. 2009; 30(19):2369-2413. 10.1093/eurhe artj/ehp285